The newly issued class C shares were converted into common shares under the company’s articles of association, bringing the total number of votes in the organization to 357,636,514. Following these updates, Sobi retains 9,631,955 common shares in its treasury. The company, which specializes in therapies for rare diseases, reported 28 billion SEK in revenue for 2025 and currently maintains a workforce of approximately 2,000 people globally. This disclosure complies with the Swedish Financial Instruments Trading Act.
In section Releases
Sobi Adjusts Share Capital Following Employee Incentive Program
Swedish Orphan Biovitrum AB has increased its total share count to 357,636,514 as of September 30, 2026. This shift reflects the issuance and subsequent conversion of 223,677 class C shares, a move designed to satisfy the company’s long-term incentive commitments for permanent staff under the All Employee Programme.
Comments (0)
No comments yet. Be the first!